Edgewell Personal Care stock holds steady as Q3 2026 sales edge higher

Published on 09/21/2026 at 17:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Edgewell Personal Care stock trades near USD 27 as of September 21, 2026, after reporting Q3 fiscal 2026 net sales of USD 570.1 million, up 1.7 percent year over year. Analysts now see an average 12 month price target of USD 31.83, above the latest opening price.

EPC, US28035Q1022, Illustration mit AI erstellt.

Edgewell Personal Care stock (ISIN US28035Q1022) is trading around USD 27 on the New York Stock Exchange as of September 21, 2026, after the personal care group reported fiscal third quarter 2026 net sales of USD 570.1 million, a 1.7 percent increase versus the prior year period. According to StockTitan, the company also reaffirmed an adjusted earnings outlook for fiscal 2026 that implies adjusted EPS in a range of USD 1.80 to USD 2.00.

Q3 2026 results show modest growth

According to StockTitan, Edgewell Personal Care Company reported net sales of USD 570.1 million in its fiscal third quarter 2026, which represents growth of 1.7 percent compared with the same quarter a year earlier and organic net sales growth of 1.1 percent. The filing summary notes that gross profit reached USD 242.5 million in this quarter, corresponding to a gross margin of 42.5 percent, while adjusted gross margin came in higher at 44.5 percent.

The same summary highlights that GAAP diluted EPS from continuing operations in Q3 fiscal 2026 was USD 0.26, down from USD 0.46 in the prior year quarter, while adjusted EPS held at USD 0.72 in both periods. This means that on an adjusted basis earnings per share were flat year over year, even as reported EPS declined, indicating that restructuring and related charges weighed on the GAAP result while underlying profitability was more stable.

Full year 2026 outlook narrows

For the full fiscal year 2026, Edgewell has updated its guidance. According to StockTitan, the company now expects reported net sales to grow in a range of 1.3 percent to 1.8 percent for the year. Management is guiding to GAAP EPS that is roughly flat to USD 0.20, while adjusted EPS is forecast between USD 1.80 and USD 2.00 and adjusted EBITDA between USD 250 million and USD 260 million in fiscal 2026.

Edgewell also continues to expect around USD 92 million of restructuring and related charges over the period, alongside a quarterly dividend of USD 0.15 per share, according to the same 8-K summary from StockTitan. For investors, this combination of modest top-line growth, ongoing cost actions and steady dividend payments frames the risk and reward profile as the company works through margin pressure in certain segments.

Analyst view and stock levels

As of September 21, 2026, Edgewell Personal Care stock carries an average analyst recommendation of Hold. According to MarketBeat, the average 12 month price target on the stock stands at USD 31.83, which is above a reported opening price of USD 27.06. The same overview notes that EPC stock opened at USD 27.06 on the latest trading day and that the shares have a 50 day moving average price of USD 28.03 compared with a 200 day moving average of USD 23.84, indicating that the stock has risen over the longer term but has recently traded slightly below its short term trend.

Based on these figures, the implied upside from the average analyst price target to the recent opening price is about USD 4.77 per share, or roughly 17.6 percent in relative terms, though individual estimates and time horizons differ. For investors, this spread between the current share price level and the consensus target reflects a view that moderate earnings and cash flow growth, combined with continued dividends, could justify a somewhat higher valuation if execution on the 2026 guidance remains on track.

Stock price snapshot

Per recent exchange data referenced by MarketBeat, Edgewell Personal Care stock most recently opened at USD 27.06 on the New York Stock Exchange, with trading in US dollars as of a session dated September 21, 2026. Using this level as a reference and the noted 200 day moving average of USD 23.84, the stock is trading several dollars above its longer term average but modestly below the 50 day moving average of USD 28.03, suggesting some consolidation after earlier gains.